Lonza is expanding its commercial-scale aseptic drug product capacity in [...]

Lonza has acquired the rights to Nona Biosciences’ transferrin receptor [...]

Lonza will expand its highly potent active pharmaceutical ingredient manufacturing [...]

InduPro has licensed Lonza’s antibody-drug conjugate technologies to support development [...]

Lonza has entered an exclusive licensing agreement with Antharis Therapeutics [...]

AmMax Bio has licensed antibody-drug conjugate technology from Lonza to [...]

Lonza has expanded its integrated DNA-to-IND biologics development offering, introducing [...]

ImmuneOncia Therapeutics and Lonza have entered into a manufacturing collaboration [...]

Lonza expands its Advanced Synthesis capabilities at Oss, integrating ADC [...]

Synaffix B.V., a Lonza company focused on clinical-stage antibody-drug conjugate [...]